首页> 美国卫生研究院文献>Pathology Research International >In Vitro Studies on the Antioxidant Property and Inhibition of α-Amylase α-Glucosidase and Angiotensin I-Converting Enzyme by Polyphenol-Rich Extracts from Cocoa (Theobroma cacao) Bean
【2h】

In Vitro Studies on the Antioxidant Property and Inhibition of α-Amylase α-Glucosidase and Angiotensin I-Converting Enzyme by Polyphenol-Rich Extracts from Cocoa (Theobroma cacao) Bean

机译:可可豆富含多酚的提取物对α-淀粉酶α-葡萄糖苷酶和血管紧张素I转化酶的抗氧化性能和抑制作用的体外研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background. This study sought to investigate the antidiabetic and antihypertensive mechanisms of cocoa (Theobroma cacao) bean through inhibition of α-amylase, α-glucosidase, angiotensin-1 converting enzyme, and oxidative stress. Methodology. The total phenol and flavonoid contents of the water extractable phytochemicals from the powdered cocoa bean were determined and the effects of the extract on α-amylase, α-glucosidase, and angiotensin-1 converting enzyme activities were investigated in vitro. Furthermore, the radicals [1,1-diphenyl-2 picrylhydrazyl (DPPH), 2,2..-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid) (ABTS), hydroxyl (OH), and nitric oxide (NO)] scavenging ability and ferric reducing antioxidant property of the extract were assessed. Results. The results revealed that the extract inhibited α-amylase (1.81 ± 0.22 mg/mL), α-glucosidase (1.84 ± 0.17 mg/mL), and angiotensin-1 converting enzyme (0.674 ± 0.06 mg/mL [lungs], 1.006 ± 0.08 mg/mL [heart]) activities in a dose-dependent manner and also showed dose-dependent radicals [DPPH (16.94 ± 1.34 mg/mL), NO (6.98 ± 0.886 mg/mL), OH (3.72 ± 0.26 mg/mL), and ABTS (15.7 ± 1.06 mmol/TEAC·g] scavenging ability. Conclusion. The inhibition of α-amylase, α-glucosidase, and angiotensin-1 converting enzyme activities by the cocoa bean extract could be part of the possible mechanism by which the extract could manage and/or prevent type-2 diabetes and hypertension.
机译:背景。本研究试图通过抑制α-淀粉酶,α-葡萄糖苷酶,血管紧张素-1转化酶和氧化应激来研究可可豆的抗糖尿病和降压机制。方法。测定可可豆粉中可水提取植物化学物质的总酚和类黄酮含量,并在体外研究提取物对α-淀粉酶,α-葡萄糖苷酶和血管紧张素-1转化酶活性的影响。此外,基团[1,1-二苯基-2吡啶并肼基(DPPH),2,2 ..-叠氮基双(3-乙基苯并噻唑啉-6-磺酸)(ABTS),羟基(OH)和一氧化氮(NO )]评估了提取物的清除能力和还原性三氧化二铁。结果。结果表明,提取物抑制α-淀粉酶(1.81±0.22 mg / mL),α-葡萄糖苷酶(1.84±0.17μmg/ mL)和血管紧张素-1转化酶(0.674±0.06μmg/ mL [肺],1.006± 0.08 mg / mL [心脏])具有剂量依赖性,并且还显示出剂量依赖性的自由基[DPPH(16.94±1.34 mg / mL),NO(6.98±0.886 mg / mL),OH(3.72±0.26 mg / mL)结论:可可豆提取物抑制α-淀粉酶,α-葡萄糖苷酶和血管紧张素-1转化酶的活性可能是其可能的机制的一部分,并具有ABTS(15.7±1.06 mmol / TEAC·g]的清除能力。通过该提取物可以控制和/或预防2型糖尿病和高血压。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号